1st Jun 2009 16:12
1 June 2009
GW Pharmaceuticals plc("GW" or "the Company")
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
The Company has today been notified that, on 29th May 2009 the personal pension scheme of Mr David Kirk, a Director of the Company, purchased 40,000 ordinary shares of 0.1p at a market price of 78 pence per share. The purchase amounts to 0.03% of the shares in issue
Following this notification Mr Kirk retains a beneficial interest in 59,500 ordinary shares of 0.1p, amounting to 0.05% of the shares in issue.
In addition, the Company has today been notified that, in order to improve liquidity and to meet institutional investor demand, on 29 May 2009 Dr Geoffrey Guy, a Director of the Company, sold 250,000 ordinary shares of 0.1p for a consideration of 78 pence per share. Dr Guy's personal pension scheme also sold 500,000 shares for a consideration of 78 pence per share.
The total of 750,000 ordinary shares sold amounts to 0.62% of the issued ordinary share capital.
Following this notification Dr Guy's retains a beneficial interest in 19,948,563 ordinary shares, amounting to 16.5% of the shares in issue.
Enquiries:
GW Pharmaceuticals plc 01980 557000
Adam George, Company Secretary
Nominated Adviser 0207 597 4000
Patrick Robb, Investec Bank plc
Related Shares:
GWP.L